Literature DB >> 12958020

Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.

Tetsuya Tanigawa1, Toshio Watanabe, Masaki Hamaguchi, Eiji Sasaki, Kazunari Tominaga, Yasuhiro Fujiwara, Nobuhide Oshitani, Takayuki Matsumoto, Kazuhide Higuchi, Tetsuo Arakawa.   

Abstract

Neutrophil infiltration mediated by TNF-alpha is associated with various types of gastric injury, whereas PGs play a crucial role in gastric defense. We examined roles of two isoforms of cyclooxygenase (COX) and PGE2 in Helicobacter pylori-induced gastritis in mice. Mice infected with H. pylori were given selective COX-1 inhibitor SC-560 (10 mg/kg), selective COX-2 inhibitor NS-398 (10 mg/kg), or nonselective COX inhibitor indomethacin (2 mg/kg) with or without 16,16-dimethyl PGE2 for 1 wk. H. pylori infection increased levels of mRNA for COX-1 and -2 in gastric tissue by 1.2-fold and 3.3-fold, respectively, accompanied by a significant increase in PGE2 production by gastric tissue. H. pylori infection significantly elevated MPO activity, a marker of neutrophil infiltration, and epithelial cell apoptosis in the stomach. SC-560 augmented MPO activity and epithelial cell apoptosis with associated reduction in PGE2 production, whereas NS-398 had the same effects without affecting PGE2 production. Inhibition of both COX-1 and -2 by indomethacin or concurrent treatment with SC-560 and NS-398 resulted in a stronger increase in MPO activity and apoptosis than inhibition of either COX-1 or -2 alone. H. pylori infection elevated TNF-alpha mRNA expression in the stomach, which was further increased by indomethacin. Effects of COX inhibitors on neutrophil infiltration, apoptosis, and TNF-alpha expression in H. pylori-infected mice were abolished by exogenous 16,16-dimethyl PGE2. In conclusion, PGE2 derived from either COX-1 or -2 is involved in regulation of gastric mucosal inflammation and contributes to maintenance of mucosal integrity during H. pylori infection via inhibition of TNF-alpha expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958020     DOI: 10.1152/ajpgi.00137.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  11 in total

1.  Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice.

Authors:  Toshio Watanabe; Kazuhide Higuchi; Koichi Taira; Eiji Sasaki; Masatsugu Shiba; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 2.  Functional oesophageal epithelial defense against acid.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.

Authors:  T Hayakawa; Y Fujiwara; M Hamaguchi; T Sugawa; M Okuyama; E Sasaki; T Watanabe; K Tominaga; N Oshitani; K Higuchi; T Arakawa
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

Review 4.  Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility.

Authors:  Koji Takeuchi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

5.  Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Kazuhide Higuchi; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Andrzej S Tarnawski; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

6.  Helicobacter pylori modulates cyclooxygenase-2 and 15-hydroxy prostaglandin dehydrogenase in gastric cancer.

Authors:  Jianqiu Zhao; Shujun Wen; Xingfen Wang; Zhiguang Zhang
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

7.  Gastritis induced by Helicobacter pylori infection in experimental rats.

Authors:  Mohamed M Elseweidy; Mona M Taha; Nahla N Younis; Khadiga S Ibrahim; Hamdi A Hamouda; Mohamed A Eldosouky; Hala Soliman
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

8.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

9.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Sureshkumar Muthupalani; Shigeo Takaishi; Peiying Yang; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

10.  The protective effects of rosmarinic acid on ethanol-induced gastritis in male rats: antioxidant defense enhancement.

Authors:  Fatemeh Heidari; Tahereh Komeili-Movahhed; Zeinab Hamidizad; Azam Moslehi
Journal:  Res Pharm Sci       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.